This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview
Kruger, Dinja

Dinja Kruger, MD

Ph.D. Student

Experience

After graduating medical school in 2013, I started as a PhD student in the VU University Medical Center at the department of Medical Oncology. Part of this research project is in cooperation with the NKI and therefore, I joined the group of Sabine Linn.

During the upcoming years, I will investigate in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer, whether biomarkers can be identified in the PI3K-Akt-mTOR pathway that predict which patients will benefit from treatment with everolimus and exemestane.